Alnylam Launches Hereditary ATTR (hATTR) Amyloidosis Campaign to Help Shorten Time to Diagnosis for Inherited and Rapidly Progressive Disease

Details

 

Image
family health history road trip
Video file

 

- Family Health History Road Trip Program Aims to Inspire Conversations About Health History and Empower Families to Take Control of Their Health -

- Genealogist and Health Educator Bernice Bennett Travels Cross-Country to Visit Members of hATTR Amyloidosis Community and Highlight How Discussing Family Health History Can Drive Earlier Diagnosis -

CAMBRIDGE, Mass.--(BUSINESS WIREexternal link, opens in a new tab)--Alnylam Pharmaceuticals, Inc.external link, opens in a new tab (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced the launch of the Family Health History Road Tripexternal link, opens in a new tab, its program designed to encourage conversations between family members about their health history so they can discuss with their doctor to better understand their risk for developing an inherited disease like hereditary ATTR (hATTR) amyloidosis. Inspired by the traditional family road trip, the program follows genealogist and health educator Bernice Bennett as she embarks on a cross-country road trip to meet with a physician expert in hATTR amyloidosis and affected families to learn more about the disease, hear patients' journeys to diagnosis and explore how knowledge of family health history can drive an earlier diagnosis.

"When we speak about family history, we often focus on the stories about what country we came from, where family immigrated to, or what types of jobs or professions they held; what we don't tend to focus on is the health history of those who have walked before us," said Bennett. "Family history is considered one of the most important risk factors for health problems. Knowing your family's health history empowers you with important information to share with your doctor when seeking a diagnosis or determining your risk for developing an inherited disease like hATTR amyloidosis."

Continue Readingexternal link, opens in a new tab